Cancer Health Disparities
Here has been substantial progress in cancer treatment, screening, diagnosis, and prevention over the past several decades, addressing cancer health disparities—such as higher cancer death rates, less frequent use of proven screening tests, and higher rates of advanced cancer diagnoses—in certain populations is an area in which progress has not kept pace.
These disparities are frequently seen in people from low-socioeconomic groups, certain racial/ethnic populations, and those who live in geographically isolated areas.
Documented cancer health disparities include: A higher incidence of a particularly aggressive form of breast cancer (the triple-negative subtype) among African American women than women of other racial/ethnic groups substantially higher rates of prostate cancer incidence and death among African American men than men of other racial/ethnic groups.
Higher rates of kidney cancer among American Indian and Alaska Natives than other racial/ethnic groups. Higher rates of liver cancer among Asian and Pacific Islanders than other racial/ethnic groups.
Higher rates of cervical cancer incidence and death among Hispanic and African American women than women of other racial/ethnic groups. Many of the same population groups that experience cancer health disparities are also significantly underrepresented in cancer clinical trials.
There has been some recent evidence of progress against cancer health disparities, including reductions in lung and prostate cancer deaths among African American men over the past decade. But researchers and public health officials agree that progress has come too slowly, and the cost of disparities—in terms of premature deaths, lost productivity, and the impact on communities—remains substantial and must be addressed. Cancer disparities and equity research is needed to understand why some groups of people may be more or less likely to develop cancer, experience cancer-related health problems, or die from cancer than other groups of people.
Related Conference of Cancer Health Disparities
21st International Conference on Breast Pathology and Cancer Diagnosis
Cancer Health Disparities Conference Speakers
Recommended Sessions
- Breast Cancer, Cancer Therapies and Breast Cancer Treatment
- Cancer Biology
- Cancer Biomarkers
- Cancer Development
- Cancer Drugs
- Cancer Epidemiology, Screening, Diagnosis & Prognosis
- Cancer Health Disparities
- Cancer Preventive Vaccines: Oncolytic Therapy & Others
- Cancer Risk Factors
- Cancer Science
- Cancer Stem Cells
- Cancer Treatment
- Cancer Vaccines
- Cardio Oncology
- Circulating Tumor Cell (CTC)
- Genetic Mutations Of Cancer
- Gynecologic Oncology
- Nanotechnology In Cancer Treatment
- Neonatal And Pediatric Oncology
- Oncology Nursing
- Oncology Research
- Organ Specific Cancer
- Phases And Types Of Clinical Trails
- Precision Medicine And Immuno-Oncology
- Pulmonary Oncology
- Radiation Oncology
- Types Of Cancers
- Veterinary Oncology
Related Journals
Are you interested in
- Advancements in Imaging Technology - RADIOLOGY AND ONCOLOGY 2024 (France)
- Alternative Treatments and Therapeutics - Cancer Science 2024 (Italy)
- Artificial Intelligence in Radiology - RADIOLOGY AND ONCOLOGY 2024 (France)
- Benign Breast Lesions: Diagnosis, Management, and Surveillance - Breast Pathology 2024 (Italy)
- Biomarkers and Predictive Factors in Breast Pathology: Translating Research into Clinical Practice - Breast Pathology 2024 (Italy)
- Breast Cancer - Cancer Science 2024 (Italy)
- Breast Cancer - World Cancer 2024 (UAE)
- Breast Cancer - Clinical Trails: - Breast Cancer Summit 2024 (Italy)
- Breast Cancer and Cell Biology - Breast Cancer 2024 (Switzerland)
- Breast Cancer And Immunology - Breast Cancer 2024 (Switzerland)
- Breast Cancer Awareness - Breast Cancer 2024 (Switzerland)
- Breast Cancer Detection, Prevention and Diagnosis - Breast Cancer 2024 (Switzerland)
- Breast Cancer during pregnancy: - Breast Cancer Summit 2024 (Italy)
- Breast Cancer Management - Breast Cancer 2024 (Switzerland)
- Breast Cancer Nursing - Breast Cancer 2024 (Switzerland)
- Breast Cancer Radiation Therapy: - Breast Cancer Summit 2024 (Italy)
- Breast Cancer Risk - Breast Cancer 2024 (Switzerland)
- Breast Cancer Staging - Breast Cancer 2024 (Switzerland)
- Breast Cancer Surgery - Breast Cancer 2024 (Switzerland)
- Breast Cancer Surgery: - Breast Cancer Summit 2024 (Italy)
- Breast Cancer Therapies: - Breast Cancer Summit 2024 (Italy)
- Breast Cancer treatment: - Breast Cancer Summit 2024 (Italy)
- Breast Cancer-Clinical Trials - Breast Cancer 2024 (Switzerland)
- Breast Cancer: - Breast Cancer Summit 2024 (Italy)
- Breast Imaging: Innovations in Radiology and Pathology Correlation - Breast Pathology 2024 (Italy)
- Breast Pathology in Pregnancy and Lactation: Challenges and Considerations - Breast Pathology 2024 (Italy)
- Cancer & Stem Cell Therapy - Cancer Meeting Summit 2024 (France)
- Cancer and Nanotechnology - World Cancer 2024 (UAE)
- Cancer Awareness and Survival - Cancer Meeting Summit 2024 (France)
- Cancer Biomarkers - Cancer Meeting Summit 2024 (France)
- Cancer Biomarkers - Cancer Science 2024 (Italy)
- Cancer Biopsy - Cancer Meeting Summit 2024 (France)
- Cancer Biopsy - World Cancer 2024 (UAE)
- Cancer Causes and Risk Factors - Cancer Meeting Summit 2024 (France)
- Cancer Cell Biology & Geneti - Cancer Meeting Summit 2024 (France)
- Cancer Drug Development - World Cancer 2024 (UAE)
- Cancer Early Detection, Diagnosis and Prognosis - Cancer Meeting Summit 2024 (France)
- Cancer Epidemiology and Prevention - RADIOLOGY AND ONCOLOGY 2024 (France)
- Cancer Epigenetics - Cancer Science 2024 (Italy)
- Cancer Genomics - World Cancer 2024 (UAE)
- Cancer Genomics & Metabolomics - Cancer Science 2024 (Italy)
- Cancer Imaging in Resource-Limited Settings - RADIOLOGY AND ONCOLOGY 2024 (France)
- Cancer Immunology - World Cancer 2024 (UAE)
- Cancer Immunology and Immunotherapy - World Cancer 2024 (UAE)
- Cancer Immunology and Tumor Microenvironment - RADIOLOGY AND ONCOLOGY 2024 (France)
- Cancer Management and Prevention - Cancer Science 2024 (Italy)
- Cancer Metastasis - Cancer Science 2024 (Italy)
- Cancer Prevention - World Cancer 2024 (UAE)
- Cancer Prevention & Research - Cancer Meeting Summit 2024 (France)
- Cancer Science - Cancer Science 2024 (Italy)
- Cancer Screening & Chemotherapy - Cancer Meeting Summit 2024 (France)
- Cancer Syndrome - World Cancer 2024 (UAE)
- Cancer Therapies - World Cancer 2024 (UAE)
- Cancer Therapy - Cancer Science 2024 (Italy)
- Cancer Vaccines - Cancer Meeting Summit 2024 (France)
- Cancer Virology - World Cancer 2024 (UAE)
- Case Studies - Breast Cancer 2024 (Switzerland)
- Chemotherapy for Breast Cancer: - Breast Cancer Summit 2024 (Italy)
- Diagnostic and Imagination of Radiation - World Cancer 2024 (UAE)
- Diagnostic Challenges: From Atypical Ductal Hyperplasia to Ductal Carcinoma In Situ - Breast Pathology 2024 (Italy)
- Diet and Lifestyle Effect on Breast Cancer - Breast Cancer 2024 (Switzerland)
- DNA Damage, Mutation and Cancer - Cancer Meeting Summit 2024 (France)
- Early Cancer Detection - RADIOLOGY AND ONCOLOGY 2024 (France)
- Early Detection and Screening - World Cancer 2024 (UAE)
- Emerging Technologies in Breast Pathology: Digital Pathology, AI, and Machine Learning - Breast Pathology 2024 (Italy)
- Endocrine and Neuroendocrine System - World Cancer 2024 (UAE)
- Epidemiology of Breast Cancer and Risk Factors - Breast Cancer 2024 (Switzerland)
- Gynaecological Cancers - Cancer Meeting Summit 2024 (France)
- Hematology- Oncology - Cancer Science 2024 (Italy)
- Imaging and Biomarker Correlation - RADIOLOGY AND ONCOLOGY 2024 (France)
- Imaging for Treatment Response Assessment - RADIOLOGY AND ONCOLOGY 2024 (France)
- Imaging in Cancer Staging - RADIOLOGY AND ONCOLOGY 2024 (France)
- Imaging in Immunotherapy - RADIOLOGY AND ONCOLOGY 2024 (France)
- Immunohistochemistry and Biomarkers in Breast Pathology - Breast Pathology 2024 (Italy)
- Immunotherapy Advances - World Cancer 2024 (UAE)
- Immunotherapy and Breast Cancer: - Breast Cancer Summit 2024 (Italy)
- Inflammatory Breast Cancer - Breast Cancer 2024 (Switzerland)
- Inflammatory Breast Cancer: Pathogenesis, Diagnosis, and Therapeutic Advances - Breast Pathology 2024 (Italy)
- Interventional Radiology in Oncology - RADIOLOGY AND ONCOLOGY 2024 (France)
- Liquid Biopsies - World Cancer 2024 (UAE)
- Lung Cancer - World Cancer 2024 (UAE)
- Male Breast Cancer Research - Breast Cancer 2024 (Switzerland)
- Male Breast Cancer Research: - Breast Cancer Summit 2024 (Italy)
- Mammography - Breast Cancer 2024 (Switzerland)
- Mammography: - Breast Cancer Summit 2024 (Italy)
- Mastectomy: - Breast Cancer Summit 2024 (Italy)
- Metastatic Breast Cancer: - Breast Cancer Summit 2024 (Italy)
- Metastatic Breast Cancer: Pathological Insights and Treatment Approaches - Breast Pathology 2024 (Italy)
- Metastatic Cancer Management - RADIOLOGY AND ONCOLOGY 2024 (France)
- Microbiome and Cancer - World Cancer 2024 (UAE)
- Molecular Pathology: Unraveling Breast Cancer Subtypes - Breast Pathology 2024 (Italy)
- Multidisciplinary Approach to Breast Pathology: Collaboration between Pathologists, Radiologists, Surgeons, and Oncologists - Breast Pathology 2024 (Italy)
- Multidisciplinary Cancer Care - RADIOLOGY AND ONCOLOGY 2024 (France)
- Nanotechnology - World Cancer 2024 (UAE)
- Neonatal & Pediatric Oncology - Cancer Meeting Summit 2024 (France)
- Neurological Cancers & Brain Tumors - Cancer Meeting Summit 2024 (France)
- Oncogenomics - Cancer Science 2024 (Italy)
- Oncology Biomarkers - World Cancer 2024 (UAE)
- Oncology Nursing and Care - Cancer Science 2024 (Italy)
- Oncology Nursing Care - Cancer Meeting Summit 2024 (France)
- Oncology Radiology, Nanotechnology - Cancer Meeting Summit 2024 (France)
- Oncolytic Virus and Cancer - Cancer Meeting Summit 2024 (France)
- Organ Specific Cancer - Cancer Meeting Summit 2024 (France)
- Organ Specific Cancer - Cancer Science 2024 (Italy)
- Pathological Assessment of Breast Core Biopsies: Pitfalls and Best Practices - Breast Pathology 2024 (Italy)
- Pathological Assessment of Breast Reconstruction: Challenges and Surgical Considerations - Breast Pathology 2024 (Italy)
- Pathology of Triple-Negative Breast Cancer: Clinical Implications and Therapeutic Strategies - Breast Pathology 2024 (Italy)
- Pediatric Cancer - World Cancer 2024 (UAE)
- Pediatric Oncology Imaging - RADIOLOGY AND ONCOLOGY 2024 (France)
- Precision Medicine in Breast Pathology: Integrating Genomics and Targeted Therapies - Breast Pathology 2024 (Italy)
- Precision Medicine in Oncology - RADIOLOGY AND ONCOLOGY 2024 (France)
- Prevention of Breast cancer: - Breast Cancer Summit 2024 (Italy)
- Prostate cancer - World Cancer 2024 (UAE)
- Psycho Oncology - World Cancer 2024 (UAE)
- Radiation Oncology Quality Assurance - RADIOLOGY AND ONCOLOGY 2024 (France)
- Radiation Safety and Dose Reduction - RADIOLOGY AND ONCOLOGY 2024 (France)
- Radiation Therapy and Oncology - RADIOLOGY AND ONCOLOGY 2024 (France)
- Radiogenomics - RADIOLOGY AND ONCOLOGY 2024 (France)
- Radiology - Breast Cancer 2024 (Switzerland)
- Radiomics - RADIOLOGY AND ONCOLOGY 2024 (France)
- Reconstruction of Breast Cancer: - Breast Cancer Summit 2024 (Italy)
- Skin Cancer - Cancer Science 2024 (Italy)
- Stem Cell Cancer - World Cancer 2024 (UAE)
- Surgical and Clinical Oncology - Cancer Meeting Summit 2024 (France)
- Therapeutic Procedure - World Cancer 2024 (UAE)
- Tissue Regeneration and Cancer - World Cancer 2024 (UAE)
- Tumor Biology - Cancer Science 2024 (Italy)
- Tumour Virology, Immunology & Cellular Pathology - Cancer Meeting Summit 2024 (France)